EY Announces Todd Schonherz of American Oncology Network, LLC as an Entrepreneur Of The Year® 2023 Florida Award Finalist

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures.

FORT MYERS, Fla., May 9, 2023Ernst & Young LLP (EY US) announced that Todd Schonherz, chief executive officer of American Oncology Network, LLC (AON), was named an Entrepreneur Of The Year® 2023 Florida Award finalist. Now in its 37th year, Entrepreneur Of The Year is one of the preeminent competitive business awards for transformative entrepreneurs and leaders of high-growth companies who are building a more equitable, sustainable and prosperous world for all.

Schonherz was selected by an independent panel of judges. Entrepreneurs were evaluated based on their demonstration of building long-term value through entrepreneurial spirit, purpose, growth and impact, among other core contributions and attributes.

“I am beyond honored to be considered a finalist for this prestigious award and have a platform to bring awareness to our AON mission of closing the cancer care gap so that every patient has access to the care they need to fight their cancer,” said Schonherz.

AON was founded in 2018 and is one of the fastest-growing networks of community oncology practices delivering local access to quality and affordable cancer care. Many community practices face significant challenges and financial pressures that lead to them either closing or being acquired by hospitals or other healthcare systems.

AON’s model safeguards the long-term sustainability of community oncology practices by addressing the triple aim of healthcare which in turn ensures patients continue to have access to high-quality, cost-effective care that is close to where they live and work. Since its inception, the company operates 76 sites of service in 17 states plus the District of Columbia.

Regional award winners will be announced on June 8, during a special celebration. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation’s most prestigious gatherings of high-growth, market-leading companies. The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur Of The Year™ Award in June 2024.  

The Entrepreneur Of The Year program has recognized more than 11,000 entrepreneurs throughout the US since its inception in 1986, and it has grown to recognize business leaders across 145 cities in over 60 countries around the world.

Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards include presenting sponsors PNC Bank, N.A.; SAP America; and the Kauffman Foundation. In Florida, sponsors also include – regional Platinum sponsors, Cresa, and DLA Piper.

About Entrepreneur Of The Year®
Entrepreneur Of The Year® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National Overall Award winners go on to compete for the EY World Entrepreneur Of The Year™ title. Visit ey.com/us/eoy.

About EY Private
As Advisors to the ambitious™, EY Private professionals possess the experience and passion to support private businesses and their owners in unlocking the full potential of their ambitions. EY Private teams offer distinct insights born from the long EY history of working with business owners and entrepreneurs. These teams support the full spectrum of private enterprises including private capital managers and investors and the portfolio businesses they fund, business owners, family businesses, family offices and entrepreneurs. Visit ey.com/us/private.

About EY
EY exists to build a better working world, helping create long-term value for clients, people and society and building trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate. Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today. EY refers to the global organization and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data, and a description of the rights individuals have under data protection legislation is available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws.

For more information about our organization, please visit ey.com. For more information about AON and Schonherz, visit https://www.aoncology.com/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians and 86 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

American Oncology Network, a Rapidly Growing Network of Community-Based Oncology Practices, Receives Strategic Investment from AEA Growth

FORT MYERS, Fla., Apr. 28, 2023American Oncology Network (“AON” or the “Company”), a rapidly growing network of community-based oncology practices, today announced that the Company has entered into a definitive agreement to receive a strategic growth investment from AEA Growth.

Since inception in late 2018, AON’s goal has been to support community-based oncology practices, providing a robust, clinically integrated platform. AON provides comprehensive support, access to revenue-diversifying adjacent services, and practice management expertise to empower physicians to make cancer care better. For patients, this translates to care-enhancing services (such as access to clinical research, a centralized medically integrated specialty pharmacy, diagnostics, and pathology), a dedicated care management team, and a variety of financial assistance programs, ensuring that patients’ experiences are at the forefront of cancer care.

AEA Growth is investing, upon the satisfaction of customary closing conditions, $65 million into AON and the proceeds of the investment will be used to help further AON’s goals of supporting community practices and improving the patient experience. AEA Growth will have a minority interest in the Company, which will continue to be majority owned and governed by licensed oncologists.

AEA Growth’s investment follows a strong period of growth for AON, which generated over $1.1 billion in revenue in 2022 (reflecting over 20% growth year-over-year). As of December 31, 2022, AON’s platform includes almost 200 providers including over 100 physicians and 30 practices across 77 locations in 17 states.

“We are excited to partner with the team at AEA Growth to continue growing the AON platform,” said AON CEO Todd Schonherz. “Over the past five years, our team at AON has invested a significant amount of capital into the AON platform which enables community-based oncology practices to operate with the benefits of our combined scale and expertise, while also allowing practices to maintain their autonomy. We believe that AEA Growth is aligned with our mission to continue investing behind our practices and to provide AON’s patients with cutting edge cancer care.”

“AON enables oncology practices to deliver best-in-class cancer care in the community, where it is both convenient and better value for patients,” said James Stith, Partner of AEA Growth. “We are thrilled to partner with AON given its differentiated value proposition to community oncology practices and strong growth.”

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians practicing across 17 states. The executive management team of AON encompasses members with an average of more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients. Learn more at AONcology.com.

About AEA Growth
AEA Growth provides technology-enabled, healthcare and software companies with flexible capital and operational resources to accelerate growth. AEA Growth targets investments in category leading, capital efficient businesses with strong customer advocacy.

AEA Growth is part of AEA Investors LP. AEA Investors was founded in 1968 by the Rockefeller, Mellon and Harriman family interests and S.G. Warburg & Co. as a private investment vehicle for a select group of industrial family offices with substantial assets. AEA has an extraordinary global network built over many years which includes leading industrial families, business executives and leaders; many of whom invest with AEA as active individual investors and/or join its portfolio company boards or act in other advisory roles. Today, AEA’s approximately 110 investment professionals operate globally with offices in New York, Stamford, San Francisco, London, Munich and Shanghai. The firm manages funds that have approximately $19 billion of invested and committed capital including the leveraged buyouts of middle market companies and small business companies, growth capital and mezzanine and senior debt investments.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

Hope Cancer Care of Nevada Continues Patient Advocacy Initiatives with the Launch of the CPAN Chapter and Other Supportive Efforts

Local oncology clinic continues to drive patient-centered care forward.

LAS VEGAS, April 24, 2023 –  Hope Cancer Care of Nevada (HCCN), community-based oncology practice and partner practice of American Oncology Network, LLC (AON), announced its patient advocacy initiatives including launching a local CPAN chapter and continuing to support cancer patients and survivors with dedicated resources.

“Patient-centered care and decision-making are how we do what is right for our patients and their families,” said HCCN Board-certified medical oncologist Raja S. Mehdi, MD. “At our clinic, we strive to deliver the highest level of care our patients deserve as well as be their advocate and voice. We are excited to be expanding our patient advocacy efforts to launch a local CPAN chapter and continue to honor our cancer survivors along the way.”

HCCN will be the first CPAN chapter in Nevada and joins over 30 practices across 17 states. The Community Oncology Alliance (COA) Patient Advocacy Network (CPAN) is a nationally recognized patient advocacy group that works to preserve access to community-based cancer clinics. The organization brings to light national and local healthcare policy regulations and issues that have the potential to impact patient care.

“Hope Cancer Care of Nevada helps patients receive state-of-the-art, personalized care close to their homes. All too often, they’re the ones that suffer the most when local, affordable cancer care is threatened by misguided government policies,” said COA Director of Patient Advocacy and Education Rose Gerber. “It is important that those involved at all levels of healthcare truly understand what community oncology practices do and go through. We are excited to welcome Dr. Mehdi and his practice to the network.”

“We are elated to learn of Hope Cancer Care of Nevada’s joining of CPAN,” said AON Chief Medical Officer Stephen “Fred” Divers, MD. “Patient care does not only occur in a patient room or infusion room nor is it only present when a patient enters the clinic until the time they leave. It is an ongoing mission to understand what is happening locally and nationally in healthcare and then ensure that patient care remains the sole priority. The growth of such advocacy networks like CPAN is only one path to changing the landscape of healthcare for the better.”

In addition to instituting the CPAN chapter, HCCN continues to support cancer survivors with a Cancer Patient Survivor Night at the Ballpark event on May 11 from 6:45 p.m. to 9:30 p.m. where additional proceeds will be donated to the nonprofit Nevada Childhood Cancer Foundation. HCCN also hosts the monthly Hope Care Support Group for patients who have any cancer type. Those attending are given a safe space to share their experiences and gain support.

“It is our duty to provide our patients with not only medical care and services but mental support and guidance,” said Mehdi. “The resources we provide at the clinic are designed to help patients along their cancer journey and to hopefully provide some comfort that they are not alone in their fight.”

HCCN has served the Las Vegas and Pahrump communities for more than 13 years, treating various cancer types and offering holistic cancer care and therapies.

HCCN joined AON in July 2019. For more information about AON, visit aoncology.com/. For more information about HCCN, visit hccnevada.com/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians and 86 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

About Hope Cancer Care of Nevada
Specialists in the diagnosis and treatment of cancer and blood disorders, Hope Cancer Care of Nevada providers have been serving patients in the Las Vegas and Pahrump, Nevada areas for more than 13 years. As a community-based practice, we offer a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at hccnevada.com/.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

American Oncology Network and Messino Cancer Centers Welcome Neuro-Oncologist Jeanette Pueschel Larson, MD, to Physician Team

Dr. Jeanette Pueschel Larson joins the practice as the newest physician.

ASHEVILLE, N.C., April 3, 2023 Messino Cancer Centers (Messino), partner practice of American Oncology Network, LLC (AON), announced the expansion of the medical team to include Board-certified neuro-oncologist Jeanette Pueschel Larson, MD. Dr. Larson is available to see patients at the Asheville clinic starting today.

“We are excited to have Dr. Larson joining our physicians’ team here at Messino,” said Martin Palmeri, MD, MBA, Board-certified medical oncologist at Messino. “Our goal is to provide comprehensive cancer care and therapies so that we can better serve our patients and their unique needs. Dr. Larson’s specialty is of great value to us and our patients. Welcome, Dr. Larson to the Messino team.”

Dr. Larson earned her medical degree from Dartmouth Medical School and went on to complete a residency in neurology and a fellowship in neuro-oncology at the Barrow Neurological Institute of St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. She then completed a working fellowship in neurological rehabilitation at Valley Physician Medicine & Rehabilitation in Phoenix, Arizona. Through her extensive education and training, she is experienced in caring for patients with aggressive brain, spine and nervous system tumors.

“I am passionate about providing patient-first care that is evidence-based and being an advocate for my patients and their families,” said Larson. “Messino Cancer Centers practices patient-first care continuously through every interaction and decision made. Joining the Messino team is an honor, and I look forward to helping them elevate cancer care in the community.”

Messino is a partner practice of AON, a network of community-based oncology practices across the nation. The partnership grants the practice access to a variety of critical support services and resources, such as an in-house specialty pharmacy and financial aid assistance for patients, so that physicians are alleviated of the burdens that come with running a full-time practice and can focus on patient care.

“Messino joined AON in January 2020, and it has been our pleasure to support them as they have continued to grow and expand their physician team,” said Dr. Stephen “Fred” Divers, AON’s chief medical officer. “We are excited to welcome Dr. Larson to AON and look forward to her contributions to Messino and the network.”

“Dr. Larson is a wonderful addition to the Messino team,” said Todd Schonherz, AON’s chief executive officer. “She exemplifies the patient-first care approach that we are proud to offer across all of our practices, and her specialty in neuro-oncology will help the practice provide more tailored cancer care to patients who, unfortunately, are facing these types of tumors. Congratulations to the practice for expanding their team.”

For more information about AON, visit aoncology.com/. For more information about Messino, visit messinocancercenters.com/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians and 86 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

About Messino Cancer Centers
Messino Cancer Centers (Messino) provides treatment for adult patients diagnosed with all types of cancer and blood disorders. Messino Cancer Centers is grounded in the Western North Carolina region and devoted to providing personalized care of the highest quality to patients in community settings, close to where they live and work and where their loved ones are close by. We are proud of our 30-year history of providing the highest quality cancer treatment that is based on research and focused on the whole person. Learn more at messinocancercenters.com/.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

American Oncology Network Continues to Close Cancer Care Gap in Community-Based Oncology

AON’s dedication to closing the cancer care gap is evident in its 2022 achievements.

FORT MYERS, Fla., Mar. 22, 2023American Oncology Network, LLC (AON), nationwide network supporting the viability of community-based oncology practices in the United States, achieved key outcomes in 2022 that have paved the way for increased growth and influence in closing the cancer care gap.

“Closing the cancer care gap is an initiative toward addressing healthcare equity and ensuring every patient has access to quality care and services,” said Stephen “Fred” Divers, MD, AON’s chief medical officer who is also an active board member of the Community Oncology Alliance (COA) and co-chairman of COA’s annual conference. “At AON, we are constantly driving toward reducing the disparities in cancer care. Supporting community oncology practices is one avenue to keep cancer care accessible and affordable for millions of Americans. These homegrown clinics benefit the community by offering the same quality care and services found in hospitals locally, reducing patients’ need to travel far for treatments, and keeping costs of care low when compared to being treated at a hospital.”

In 2022, AON achieved the following outcomes, directly influencing the cancer care gap:

  • Processed 1.25 million clinical tests through the in-house laboratory.
  • Secured $47.56 million in total pharmacy patient assistance for 3,878 patients.
  • Sourced over $3.5 million in drug replacement and $52.8 million in co-pay assistance for over 4,700 patients.
  • Assisted in enrolling 263 patients into clinical trials and offered more than 150 clinical trials throughout the network.
  • Reduced healthcare costs (patient and payer savings and provider cost avoidance) by $56.21 million by using biosimilar drugs when appropriate.

“Working toward healthcare equity is a global shift and team effort from all involved in healthcare and across disciplines,” said Todd Schonherz, AON’s chief executive offer. “While it is a large-scale effort, we can make our impact on improving this area. Our goal is not met until accessible and equitable cancer care is available to all. We celebrate our 2022 achievements but recognize that we must build upon what we have created to help more people overcome the barriers that keep them from receiving care.”

AON has dedicated 2023 to driving equity forward in oncology care. Such initiatives include delivering precision medicine across its practice sites and advocating for it as a standard of care; adopting next-generation sequencing to identify genetic tumor mutations to better align therapies for treatment; and providing structure and organization to clinical records and genomic data.

AON will be attending the Community Oncology Conference, hosted by Community Oncology Alliance (COA) on March 23 and 24. Company leaders and representatives will be available for more information on how AON can help practices stay independent and thrive and close the cancer care gap in their communities. Additionally, AON’s Chief Executive Officer Schonherz and Chief Pharmacy and Clinical Services Officer James Gilmore will serve as panelists for two conference sessions. For more information on the conference, agenda and speakers, visit coaconference.com/.

For more information about AON, visit aoncology.com/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians and 86 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

Messino Cancer Centers Expands Physician Team With Medical Oncologist Eric Luk

American Oncology Network partner practice welcomes the new medical oncologist to the physician team.

ASHEVILLE, N.C., March 1, 2023 Messino Cancer Centers (Messino), one of the largest partner practices of the fast-growing community oncology organization American Oncology Network, LLC (AON), expanded its physician team to include Board-certified medical oncologist Eric Luk, MD. Dr. Luk joined today and is accepting new patients at the Asheville and Sylva locations.

“We are excited to grow our team and have Dr. Luk join us,” said Christopher Chay, MD, medical oncologist at Messino. “His approach to patient care aligns with how we run our practice, and his experienced background in oncology will be invaluable to our patients.”

Luk attended Tulane University School of Medicine, receiving his medical degree. He completed an internal medicine residency at the University of Massachusetts Chan Medical School and a hematology and oncology fellowship at Ochsner Health. He is a specialist in thoracic oncology and carries experience treating various aggressive cancers including tumors of the head, neck and brain.

“I focus on patient-centered care first and foremost, finding ways to improve my patients’ quality of life,” said Luk. “By educating my patients on their diagnosis and offering insights into recommended therapies, I can help them make more informed health decisions. I am honored to be a part of my patients’ cancer journey. I look forward to helping Asheville and the surrounding communities and joining the physicians at Messino Cancer Centers.”

“Congratulations to Messino Cancer Centers for expanding their team,” said AON Chief Medical Officer Stephen “Fred” Divers, MD. “Dr. Luk’s experience is impressive, and we welcome him to our vast network of skilled community oncologists and look forward to his contributions.”

Messino has been a partner practice of AON since January 2020. By being a part of the network, the practice has access to support and resources that single-site practices lack, such as an in-house specialty pharmacy for oral oncolytic medications and various administrative services, allowing the physicians to focus on patient-centered care.

“AON is comprised of skilled oncologists who are passionate about elevating health and access to care in their communities, and Dr. Luk is no exception,” said AON Chief Executive Officer Todd Schonherz. “I am always eager to learn of new oncologists joining one of our practices because it shows the viability of community-based oncology practices. We cannot succeed in our mission without the commitment of our physicians. Welcome, Dr. Luk.”

For more information about AON, visit aoncology.com/. For more information about Messino, visit messinocancercenters.com/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians and 86 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

About Messino Cancer Centers
Messino Cancer Centers (Messino) provides treatment for adult patients diagnosed with all types of cancer and blood disorders. Messino Cancer Centers is grounded in the Western North Carolina region and devoted to providing personalized care of the highest quality to patients in community settings, close to where they live and work and where their loved ones are close by. We are proud of our 30-year history of providing the highest quality cancer treatment that is based on research and focused on the whole person. Learn more at messinocancercenters.com/.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

Greater Washington Oncology Associates Announces Clinic Relocation

Local oncology practice relocates to a new office to provide better patient care and services.

WASHINGTON D.C., Feb. 20, 2023 – Greater Washington Oncology Associates (GWOA), a community oncology partner practice of American Oncology Network, LLC (AON), announced the relocation of its clinic from the south tower to the north tower at 106 Irving Street Northwest, Suite 4100, Washington, D.C. The practice has continued to see patients during the construction of the new space and is operational in the new clinic starting today.

“GWOA’s new office is equipped to deliver the same personalized cancer care that has been established, and patients have continued their care journey without interruption,” said GWOA’s Board-certified medical oncologist Ram S. Trehan, MD. “It is our duty to provide a space that has the necessary services available for us to treat our patients holistically, including creating an environment of healing and peace for our patients and their families.”

The clinic includes an exam room for private patient consulting, an on-site lab for quick blood draws and other orders and an in-office infusion room with nine chairs for patients to receive treatments. Community-based oncology practices, such as GWOA, are designed to locally provide the latest in cancer care, making care accessible and reducing the time patients may spend traveling to receive treatment.

“We encourage our practices to evaluate their clinic spaces often to ensure the current surroundings meet the needs of patients on a care and treatment level as well as a comfort level,” said AON Chief Medical Officer Stephen “Fred” Divers, MD. “GWOA’s relocation, while not far, is an example of a practice continuously evolving operationally to put patient care at the forefront of their offerings.”

GWOA joined AON in March 2021. AON is a network comprised of community-based oncology practices across the nation and is dedicated to providing accessible cancer care; addressing the various disparities present in healthcare; and offering its practices expanded resources, centralized services and operational support.

For more information about GWOA, visit https://www.gwoa.com/. For more information about AON, visit https://www.aoncology.com/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 107 physicians and 89 nurse practitioners and physician assistants practicing across 18 states . The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com

About Greater Washington Oncology Associates
Greater Washington Oncology Associates (GWOA) has been providing the highest level of cancer care in the greater Washington D.C. metro area and suburban Maryland since 1990. The main location is in Silver Spring, Md. with satellite offices in Rockville, Washington D.C., and Germantown. GWOA is committed to providing patients with the latest in cancer detection and treatment options. Specializing in cancer and blood disorders, GWOA’s highly skilled team works together at every stage of the diagnosis offering personalized cancer treatment to help make the best decisions in the fight against cancer. Learn more at https://www.gwoa.com/.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network’s In-House Specialty Pharmacy Re-Accredited by URAC

The specialty pharmacy received accreditation with zero deficiencies after a rigorous review.

FORT MYERS, Fla., Jan. 30, 2023 – The American Oncology Network, LLC (AON) in-house specialty pharmacy received re-accreditation with zero deficiencies through URAC. By receiving re-accreditation, the pharmacy has continued to demonstrate a comprehensive commitment to quality care, improved processes and better patient outcomes.

“We applaud the AON specialty pharmacy for once again achieving URAC accreditation. With this distinction, the pharmacy demonstrates excellence in quality health care delivery and their commitment to ensuring patient safety,” said URAC President and CEO Shawn Griffin, M.D.

“We are elated to have received re-accreditation status,” said AON Pharmacy Senior Director Doug Braun, CSP, PharmD, RPh. “Pharmacy accreditation shows our partners, payers and patients that our pharmacy meets the strictest standards and can assure them of the highest quality in all areas of the specialized clinical services.”

The AON specialty pharmacy serves more than 100 physicians by delivering oral cancer medications directly to patients — filling over 32,000 prescriptions in 2022 alone — and has access to most of the available oral oncolytic medications. Additionally, the pharmacy supports patients with financial assistance, insurance coordination, clinical assistance, treatment education and 24/7 patient and clinical support.

“It is our mission across the organization to meet the rigorous quality standards that have become the acceptable criterion in the industry,” said AON Chief Pharmacy and Clinical Services Officer James Gilmore. “URAC is an esteemed accrediting body that has set the benchmark for specialty pharmacies, and we are honored to have received their accrediting seal once again.”

“Pharmacies and related pharmaceutical services play a critical role in the health care delivery system now more than ever. Given the complicated nature of chronic disease, pharmacies like the AON specialty pharmacy do much more than simply fill a prescription. As trusted experts at the frontline of care delivery, they often provide targeted patient support and education to ensure proper medication management,” said Griffin.

“The pharmacy team works tirelessly to ensure we adhere to the highest standards of prescription fulfillment and delivery. It is a team effort that I am proud to recognize and celebrate,” said Braun.

The pharmacy will be eligible for re-accreditation in 2026.

For more information about AON specialty pharmacy, visit https://www.aoncology.com/pharmacy/. For more information about URAC specialty pharmacy accreditation, visit https://www.urac.org/accreditation-cert/specialty-pharmacy/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 107 physicians and 89 nurse practitioners and physician assistants practicing across 18 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at AONcology.com.

About URAC
Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting healthcare quality and patient safety through renowned accreditation programs. URAC develops its evidence-based standards in collaboration with a wide array of stakeholders and industry experts. The company’s portfolio of accreditation and certification programs spans the healthcare industry, addressing healthcare management and operations, pharmacies, telehealth, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability. Learn more at urac.org.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

Laura Wood, Director of Marketing and CommunicationsURAC
lwood@urac.org

American Oncology Network Appoints Chairman and Vice Chairman of the Board of Managers

AON announces the newest leadership to join the Board of Managers.

FORT MYERS, Fla., Jan. 25, 2023American Oncology Network, LLC (AON), a fast-growing organization supporting community-based oncology practices across the nation, announced the appointment of medical oncologist Shalin R. Shah, DO, as chairman and medical oncologist Stephen “Fred” Divers, MD, as vice chairman of AON’s Board of Managers, effective January 1.

Newly appointed Chairman Dr. Shah joined the Board of Managers in January 2022 and has served as the vice chairman. He is a medical oncologist with the Florida Cancer Specialists & Research Institute and practices in Tampa, Florida. In addition to being on the AON Board of Managers, Dr. Shah has served multiple terms on various boards including the Florida Society of Clinical Oncology and others in healthcare, technology and education.

“Serving as vice chairman this past year has been a rewarding experience,” said Dr. Shah. “I am eager to continue serving AON as the chairman and look forward to being part of the growth and expansion of the network.”

“Dr. Shah has brought great value to the company,” said AON Chief Executive Officer Todd Schonherz. “He is passionate about community oncology and breaking down the barriers to cancer care to ensure equitable access to healthcare in both urban and rural areas. As the company expands its reach and impact, it is important to bring on individuals aligned with our mission, just as Dr. Shah is, to continue providing value to those in our network.”

Dr. Divers joined the AON Board of Managers in January 2022 and is a medical oncologist at AON’s partner practice Genesis Cancer and Blood Institute in Hot Springs, Arkansas. He has been serving as AON’s chief medical officer since May 2022 and is chairman of AON’s advisory board. Dr. Divers received his medical degree from Louisiana State University, completed an internal medicine residency at the University of North Carolina at Chapel Hill and then attended an oncology-hematology fellowship at the University of Alabama.

“I am honored to continue my journey with AON as the vice chairman of the Board of Managers,” said Divers. “AON’s mission is one that aligns with my own — ensuring the viability of community oncology practices. Being a part of such an organization has been a rewarding experience, and I look forward to serving in this new position on the Board.”

“It is with great pleasure that Dr. Divers, one of our very own AON physicians, is appointed as vice chairman,” said Schonherz. “AON would not be where it is today without the guidance of Dr. Divers and his dedication to the company and its success.”

For more information about AON and its executive board, visit https://www.aoncology.com/ and https://www.aoncology.com/leadership/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 107 physicians and 89 nurse practitioners and physician assistants practicing across 18 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

American Oncology Network Appoints New Board of Managers Members, Announces Resignation of Two Members

AON celebrates its Board of Managers’ appointments and retirements.

FORT MYERS, Fla., Jan. 24, 2023American Oncology Network, LLC (AON), a fast-growing organization supporting community-based oncology practices across the nation, announced the addition of medical oncologists Stephen “Fred” Divers, MD, and Vance M. Wright-Browne, MD, to the Board of Managers, effective January 1. Douglas Heldreth, MD, Vipul Patel, MD, and Shalin R. Shah, DO, will continue to serve as members of AON’s Board of Managers.

“We are pleased to welcome both Dr. Divers and Dr. Wright-Browne to our board,” said AON Chief Executive Officer Todd Schonherz. “With their vast knowledge and experience in oncology and their true alignment with AON’s mission and vision, they will, without a doubt, provide the guidance needed to help us continue supporting community oncology practices and growing our network.”

Dr. Divers received his medical degree from Louisiana State University, completed an internal medicine residency at the University of North Carolina at Chapel Hill and then attended an oncology-hematology fellowship at the University of Alabama. Currently, he is a medical oncologist at AON’s partner practice Genesis Cancer and Blood Institute in Hot Springs, Arkansas. Dr. Divers also serves as AON’s chief medical officer and chairman of AON’s advisory board.

“I am honored to be selected to join the AON Board of Managers,” said Divers. “I am passionate about community oncology and being part of an organization such as AON that works hard to preserve community oncology is a rewarding experience.”

Dr. Wright-Browne received her medical degree from the University of West Indies, completed a residency program at the University of Connecticut and then attended an oncology-hematology fellowship at the University of Texas MD Anderson Cancer Center. She is Board certified in medical oncology and hematology. She practices at the Florida Cancer Specialists and Research Institute in Port Charlotte, Florida.

“Throughout my career, I have had the opportunity to help many people through their cancer journeys,” said Wright-Browne. “I am eager to continue serving cancer patients in a new way by joining AON’s Board of Managers.”

Effective January 1, Stephen Orman, MD, and Daniel Spitz, MD, retired from their roles on the Board of Managers. Dr. Orman and Dr. Spitz had served on the Board of Managers since AON’s founding in 2018.

“We are greatly appreciative to Dr. Orman and Dr. Spitz for their dedication to helping AON grow in the early years and positioning the organization for expansion,” said Schonherz. “They have been incredibly valuable advisors, and on behalf of the organization, we thank them and wish them well.”

For more information about AON and its executive board, visit https://www.aoncology.com/ and https://www.aoncology.com/leadership/.

###

About American Oncology Network, LLC
The American Oncology Network, LLC (AON), an Inc. 5000-recognized company, is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 107 physicians and 89 nurse practitioners and physician assistants practicing across 18 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com